Ensign Peak Advisors, Inc United Therapeutics Corp Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 37,017 shares of UTHR stock, worth $13.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
37,017
Previous 33,677 9.92%
Holding current value
$13.8 Million
Previous $10.7 Million 23.66%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $1.04 Million - $1.21 Million
3,340 Added 9.92%
37,017 $13.3 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $1.64 Million - $2.3 Million
7,205 Added 27.22%
33,677 $10.7 Million
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $1.27 Million - $1.5 Million
-6,018 Reduced 18.52%
26,472 $6.08 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $265,591 - $317,577
-1,236 Reduced 3.66%
32,490 $7.14 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $441,432 - $517,332
-2,084 Reduced 5.82%
33,726 $7.62 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $3.13 Million - $3.55 Million
15,250 Added 74.17%
35,810 $7.91 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $962,288 - $1.25 Million
4,518 Added 28.16%
20,560 $4.6 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $12.4 Million - $16.8 Million
-60,015 Reduced 78.91%
16,042 $4.46 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $2.36 Million - $2.84 Million
11,615 Added 18.02%
76,057 $15.9 Million
Q2 2022

Aug 12, 2022
SELL
$174.81 - $241.14 $129,359 - $178,443
-740 Reduced 1.14%
64,442 $15.2 Million
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $1.11 Million - $1.43 Million
6,675 Added 11.41%
65,182 $11.7 Million
Q4 2021

Feb 11, 2022
SELL
$184.32 - $216.08 $2.59 Million - $3.04 Million
-14,053 Reduced 19.37%
58,507 $12.6 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $4.54 Million - $5.42 Million
25,235 Added 53.32%
72,560 $13.4 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $369,067 - $458,828
-2,165 Reduced 4.37%
47,325 $8.49 Million
Q1 2021

May 12, 2021
BUY
$153.94 - $174.85 $201,507 - $228,878
1,309 Added 2.72%
49,490 $8.28 Million
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $26.7 Million - $39.7 Million
-261,873 Reduced 84.46%
48,181 $7.31 Million
Q3 2020

Nov 12, 2020
BUY
$99.9 - $121.13 $16.8 Million - $20.4 Million
168,249 Added 118.65%
310,054 $31.3 Million
Q2 2020

Aug 12, 2020
BUY
$92.74 - $125.82 $8.95 Million - $12.1 Million
96,521 Added 213.15%
141,805 $17.2 Million
Q1 2020

May 11, 2020
BUY
$79.39 - $115.35 $602,967 - $876,083
7,595 Added 20.15%
45,284 $4.29 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $2.95 Million - $3.59 Million
37,689 New
37,689 $3.32 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email